Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

1.

Krüppel-like factor 4, a tumor suppressor in hepatocellular carcinoma cells reverts epithelial mesenchymal transition by suppressing slug expression.

Lin ZS, Chu HC, Yen YC, Lewis BC, Chen YW.

PLoS One. 2012;7(8):e43593. doi: 10.1371/journal.pone.0043593. Epub 2012 Aug 24. Erratum in: PLoS One. 2013;8(12). doi:10.1371/annotation/af3b480b-2a5a-4483-a98d-82476b314ec1.

PMID:
22937066
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Dysregulated Krüppel-like factor 4 and vitamin D receptor signaling contribute to progression of hepatocellular carcinoma.

Li Q, Gao Y, Jia Z, Mishra L, Guo K, Li Z, Le X, Wei D, Huang S, Xie K.

Gastroenterology. 2012 Sep;143(3):799-810.e1-2. doi: 10.1053/j.gastro.2012.05.043. Epub 2012 Jun 4.

PMID:
22677193
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Epigenetic alterations of Krüppel-like factor 4 and its tumor suppressor function in renal cell carcinoma.

Li H, Wang J, Xiao W, Xia D, Lang B, Yu G, Guo X, Guan W, Wang Z, Hu Z, Liu J, Ye Z, Xu H.

Carcinogenesis. 2013 Oct;34(10):2262-70. doi: 10.1093/carcin/bgt189. Epub 2013 May 30.

PMID:
23722653
[PubMed - indexed for MEDLINE]
4.

Critical and reciprocal regulation of KLF4 and SLUG in transforming growth factor β-initiated prostate cancer epithelial-mesenchymal transition.

Liu YN, Abou-Kheir W, Yin JJ, Fang L, Hynes P, Casey O, Hu D, Wan Y, Seng V, Sheppard-Tillman H, Martin P, Kelly K.

Mol Cell Biol. 2012 Mar;32(5):941-53. doi: 10.1128/MCB.06306-11. Epub 2011 Dec 27.

PMID:
22203039
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Krüppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer.

Yori JL, Seachrist DD, Johnson E, Lozada KL, Abdul-Karim FW, Chodosh LA, Schiemann WP, Keri RA.

Neoplasia. 2011 Jul;13(7):601-10.

PMID:
21750654
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

HAb18G/CD147 promotes epithelial-mesenchymal transition through TGF-β signaling and is transcriptionally regulated by Slug.

Wu J, Ru NY, Zhang Y, Li Y, Wei D, Ren Z, Huang XF, Chen ZN, Bian H.

Oncogene. 2011 Oct 27;30(43):4410-27. doi: 10.1038/onc.2011.149. Epub 2011 May 2.

PMID:
21532623
[PubMed - indexed for MEDLINE]
7.

Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1α in hepatocellular carcinoma.

Zhang L, Huang G, Li X, Zhang Y, Jiang Y, Shen J, Liu J, Wang Q, Zhu J, Feng X, Dong J, Qian C.

BMC Cancer. 2013 Mar 9;13:108. doi: 10.1186/1471-2407-13-108.

PMID:
23496980
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.

Wang SP, Zhou HJ, Chen XP, Ren GY, Ruan XX, Zhang Y, Zhang RL, Chen J.

J Exp Clin Cancer Res. 2007 Mar;26(1):117-24.

PMID:
17550140
[PubMed - indexed for MEDLINE]
9.

MicroRNA-9 enhances migration and invasion through KLF17 in hepatocellular carcinoma.

Sun Z, Han Q, Zhou N, Wang S, Lu S, Bai C, Zhao RC.

Mol Oncol. 2013 Oct;7(5):884-94. doi: 10.1016/j.molonc.2013.04.007. Epub 2013 Apr 25.

PMID:
23684102
[PubMed - indexed for MEDLINE]
10.

The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion.

Fenouille N, Tichet M, Dufies M, Pottier A, Mogha A, Soo JK, Rocchi S, Mallavialle A, Galibert MD, Khammari A, Lacour JP, Ballotti R, Deckert M, Tartare-Deckert S.

PLoS One. 2012;7(7):e40378. doi: 10.1371/journal.pone.0040378. Epub 2012 Jul 20.

PMID:
22911700
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Correlation between Slug transcription factor and miR-221 in MDA-MB-231 breast cancer cells.

Lambertini E, Lolli A, Vezzali F, Penolazzi L, Gambari R, Piva R.

BMC Cancer. 2012 Oct 2;12:445. doi: 10.1186/1471-2407-12-445.

PMID:
23031797
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

The Kruppel-like KLF4 transcription factor, a novel regulator of urokinase receptor expression, drives synthesis of this binding site in colonic crypt luminal surface epithelial cells.

Wang H, Yang L, Jamaluddin MS, Boyd DD.

J Biol Chem. 2004 May 21;279(21):22674-83. Epub 2004 Mar 18.

PMID:
15031282
[PubMed - indexed for MEDLINE]
Free Article
13.

Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.

Wu K, Zeng J, Zhou J, Fan J, Chen Y, Wang Z, Zhang T, Wang X, He D.

Urol Oncol. 2013 Nov;31(8):1751-60. doi: 10.1016/j.urolonc.2012.02.001. Epub 2012 Mar 14.

PMID:
22421353
[PubMed - indexed for MEDLINE]
14.

Kruppel-like factor 4 inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expression.

Yori JL, Johnson E, Zhou G, Jain MK, Keri RA.

J Biol Chem. 2010 May 28;285(22):16854-63. doi: 10.1074/jbc.M110.114546. Epub 2010 Mar 31.

PMID:
20356845
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Transcriptional activation of ZEB1 by Slug leads to cooperative regulation of the epithelial-mesenchymal transition-like phenotype in melanoma.

Wels C, Joshi S, Koefinger P, Bergler H, Schaider H.

J Invest Dermatol. 2011 Sep;131(9):1877-85. doi: 10.1038/jid.2011.142. Epub 2011 May 19.

PMID:
21593765
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.

Wang YP, Yu GR, Lee MJ, Lee SY, Chu IS, Leem SH, Kim DG.

Hepatology. 2013 Oct;58(4):1349-61. doi: 10.1002/hep.26467. Epub 2013 Aug 7.

PMID:
23696034
[PubMed - indexed for MEDLINE]
17.

Runt-related transcription factor 3 reverses epithelial-mesenchymal transition in hepatocellular carcinoma.

Tanaka S, Shiraha H, Nakanishi Y, Nishina S, Matsubara M, Horiguchi S, Takaoka N, Iwamuro M, Kataoka J, Kuwaki K, Hagihara H, Toshimori J, Ohnishi H, Takaki A, Nakamura S, Nouso K, Yagi T, Yamamoto K.

Int J Cancer. 2012 Dec 1;131(11):2537-46. doi: 10.1002/ijc.27575. Epub 2012 Apr 24.

PMID:
22488108
[PubMed - indexed for MEDLINE]
18.

Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.

Zhao XL, Sun T, Che N, Sun D, Zhao N, Dong XY, Gu Q, Yao Z, Sun BC.

J Cell Mol Med. 2011 Mar;15(3):691-700. doi: 10.1111/j.1582-4934.2010.01052.x.

PMID:
20219012
[PubMed - indexed for MEDLINE]
19.

Deficiency of the Kruppel-like factor KLF4 correlates with increased cell proliferation and enhanced skin tumorigenesis.

Li J, Zheng H, Yu F, Yu T, Liu C, Huang S, Wang TC, Ai W.

Carcinogenesis. 2012 Jun;33(6):1239-46. doi: 10.1093/carcin/bgs143. Epub 2012 Apr 9.

PMID:
22491752
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

BVES inhibition triggers epithelial-mesenchymal transition in human hepatocellular carcinoma.

Han P, Fu Y, Luo M, He J, Liu J, Liao J, Tian D, Yan W.

Dig Dis Sci. 2014 May;59(5):992-1000. doi: 10.1007/s10620-013-2992-3. Epub 2014 Jan 18.

PMID:
24442236
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk